ChAdOx1 nCoV-19 vaccine does not protect against South African SARS-CoV-2 variant
Results of a randomized, double-blind, placebo-controlled trial conducted in South Africa show that the ChAdOx1 nCoV-19 (AZD1222) vaccine at Oxford has no efficacy against the B.1.351 variant in pr…
.jpg)